ERIN HAUG: Open Payments
NPI 1790447514 · KYLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$255 in 8 payments from 6 companies in 2025. Trend: 2023 $50 · 2024 $14 · 2025 $255
Food & beverage: $255
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $119 |
| Sequel Med Tech, LLC | 2 | $44 |
| Alvogen Inc | 1 | $24 |
| Ascendis Pharma Endocrinology Inc | 1 | $23 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $23 |
| Insulet Corporation | 1 | $22 |
Products named: Wegovy, TWIIST, TERIPARATIDE, Yorvipath, ISTURISA, Omnipod.
Industry payments across TX — which companies pay providers there.
